|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD显示文摘 | Casanova C Celli B R Tost L | 2000 | Chest2000，118，： | 2 |
| 2 | Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis显示文摘 | Salvatore Modica Michele Petruzzelli Elena Bellafante Stefania Murzilli Lorena Salvatore Nicola Celli Giuseppe Di Tullio Giuseppe Palasciano Tarek Moustafa Emina Halilbasic Michael Trauner Antonio Moschetta | 2012 | Gastroenterology2012，，2： | 2 |
| 3 | 为期四年的临床试验对噻托溴铵在慢性阻塞性肺疾病中的疗程评价显示文摘背景和目的:进一步观察噻托溴铵治疗COPD的长期效果。方法:通过随机、双盲试验,比较为期4年的噻托溴铵治疗COPD患者的疗效,4年期间允许患者使用除吸入抗胆碱能药物以外的任何呼吸科常用药物。要求患者年龄在40岁以上,使用支气管舒张剂后FEV1占预计值%≤70%,且FEV,/FVC占预计值%70%。主要终点是从第30天开始使用支气管舒张剂前后FEV1平均下降率。次要终点包括FVC测量值、圣乔治呼吸问卷(SGRQ)结果的变化、COPD急性加重以及病死率。结果:共入组5993例, | Tashkin DP Celli B Senn S 金建敏 孙永昌 | 2009 | 中华结核和呼吸杂志2009，32，3： | 2 |
| 4 | Respiratory muscle and cardiopulmonary function during exercise in very severe COPD显示文摘 | Montes de Oca M Rassulo J Celli BR | 1996 | Am J Respir Crit Care Med1996，154，： | 1 |
| 5 | Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ ERS position paper显示文摘 | Celli BR MacNee W ATS/ ERS Tast Force | 2004 | Eur Respir J2004，23，6： | 1 |
| 6 | A 4-year trial of tiotropium in chronic obstructive pulmonary disease显示文摘 | Tashkin DP Celli B Senn S | 2008 | N Engl J Med2008，359，15： | 1 |
| 7 | Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘 | Calverley PM Anderson JA Celli B | 2007 | N Engl J Med2007，356，8： | 1 |
| 8 | Tiotropium HandiHal- er in the treatment of COPD : a safety review 显示文摘 | Kesten S Celli B Deeramer M | 2009 | Int J Chron Obstruct Pulmon Dis2009，4，： | 1 |
| 9 | Systemic manifestations and comorbidities of COPD显示文摘 | Barnes PJ Celli BR | 2009 | Eur Respir J2009，33，： | 1 |
| 10 | A 4-year trial oftiotropium in chronic obstructive pulmonary disease 显示文摘 | Tashkin DP Celli B Senn S | 2008 | NEngl J Med2008，359，15： | 1 |
| 11 | Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD显示文摘 | R. Graham Barr Bartolome R. Celli David M. Mannino Thomas Petty Stephen I. Rennard Frank C. Sciurba James K. Stoller Byron M. Thomashow Gerard M. Turino | 2009 | The American Journal of Medicine2009，，4： | 1 |
| 12 | Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease 显示文摘 | Celli B R Locantore N Yates J | 2012 | American journal of respiratory and critical care medicine2012，185，10： | 1 |
| 13 | The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease显示文摘 | Celli BR Cote CG Marin JM | 2004 | N Engl J Med2004，350，10： | 1 |
| 14 | Perioperative respiratoiy care of the patient undergoing upper abdominal surgery显示文摘 | Celli BR | 1993 | Clin Chest Med1993，14，： | 1 |
| 15 | Brain abscess as a complication of cravial traction显示文摘 | Celli P Palatinsky E | 1985 | Surg Neurol1985，23，6： | 1 |
| 16 | Standards for the diagnosis and treatment of patients with COPD:A summary of the ATS/ERS显示文摘 | Celli BR Mac NW | 2004 | Eur Respir J2004，23，： | 1 |
| 17 | Update on the Management of COPD 显示文摘 | Celli BR | 2008 | Chest2008，133，6： | 1 |
| 18 | Bcl-2 isover ex-pressed and alters the threshold for apoptosis ina eholangioearcinoma cell line J显示文摘 | HARNOSIS DM QUE FG CELLI A | 1997 | Hepatol1997，26，4： | 1 |
| 19 | The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease 显示文摘 | Celli BR Cote CG Marin JM | 2004 | N Engl J Med2004，350，10： | 1 |
| 20 | Heterozygous germline mutations in thep53 homologp63 are the cause of EEC syndrome 显示文摘 | Celli J Duijf P Hamel BC | 1999 | Ce111999，99，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员